{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:17:43Z","timestamp":1792592263356,"version":"4.5.0"},"reference-count":90,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/ajg.2016.517","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T08:01:44Z","timestamp":1482220904000},"page":"18-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1083,"title":["ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries"],"prefix":"10.14309","volume":"112","author":[{"given":"Paul Y","family":"Kwo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210210","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"Br Med J"},{"key":"R2-13-20210210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOG.0000000000000167","article-title":"Noninvasive assessment of liver function.","volume":"31","author":"Helmke","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"key":"R3-13-20210210","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1172\/JCI103055","article-title":"Transaminase activity in human blood.","volume":"34","author":"Karmen","year":"1955","journal-title":"J Clin Invest"},{"key":"R5-13-20210210","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/clinchem\/46.12.2027","article-title":"Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin Chem"},{"key":"R6-13-20210210","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin Chem"},{"key":"R7-13-20210210","first-page":"90","article-title":"Variations in the phosphatase activity of the blood in disease.","volume":"11","author":"Roberts","year":"1930","journal-title":"Br J Exp Pathol"},{"key":"R8-13-20210210","first-page":"923","article-title":"Relationship between the effects of a high-fat meal and blood group in determination of alkaline phosphatase activity.","volume":"59","author":"Matsushita","year":"2011","journal-title":"Rinsho Byori"},{"key":"R10-13-20210210","first-page":"497","article-title":"Clinical significance of an increased or decreased serum alkaline phosphatase level.","volume":"102","author":"Wolf","year":"1978","journal-title":"Arch Pathol Lab Med"},{"key":"R11-13-20210210","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJM197201272860407","article-title":"Alkaline phosphatase.","volume":"286","author":"Kaplan","year":"1972","journal-title":"N Engl J Med"},{"key":"R12-13-20210210","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/gut.23.8.643","article-title":"Measurement of serum bilirubin and its mono-and diconjugates: application to patients with hepatobiliary disease.","volume":"23","author":"Scharschmidt","year":"1982","journal-title":"Gut"},{"key":"R13-13-20210210","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archinternmed.2007.131","article-title":"Creer and Nonalcoholic Steatohepatitis Clinical Research Network. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels.","volume":"168","author":"Neuschwander-Tetri","year":"2008","journal-title":"Arch Intern Med"},{"key":"R14-13-20210210","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/hep.23200","article-title":"Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study.","volume":"50","author":"Dutta","year":"2009","journal-title":"Hepatology"},{"key":"R15-13-20210210","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1515\/CCLM.2010.315","article-title":"Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and -glutamyl transferase (GGT) in serum: results from an IFCC multicenter study.","volume":"48","author":"Ceriotti","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"R16-13-20210210","first-page":"349","article-title":"Liver function in moderate obesitystudy in 534 moderately obese subjects among 4613 male company employees.","volume":"10","author":"Nomura","year":"1986","journal-title":"Int J Obes"},{"key":"R17-13-20210210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1423-0410.1988.tb05083.x","article-title":"Persistent alanine aminotransferase elevation in healthy Swedish blood donorsmainly caused by obesity.","volume":"55","author":"Wejstal","year":"1988","journal-title":"Vox Sang"},{"key":"R18-13-20210210","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.510270505","article-title":"Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.","volume":"27","author":"Piton","year":"1998","journal-title":"Hepatology"},{"key":"R19-13-20210210","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.22109","article-title":"Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.","volume":"47","author":"Kim","year":"2008","journal-title":"Hepatology"},{"key":"R20-13-20210210","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/gast.2002.36061","article-title":"AGA technical review on the evaluation of liver chemistry tests.","volume":"123","author":"Green","year":"2002","journal-title":"Gastroenterology"},{"key":"R21-13-20210210","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients.","volume":"342","author":"Pratt","year":"2000","journal-title":"N Engl J Med"},{"key":"R22-13-20210210","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R23-13-20210210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009.","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"R24-13-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels.","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"R25-13-20210210","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.23505","article-title":"Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.","volume":"51","author":"Lee","year":"2010","journal-title":"Hepatology"},{"key":"R26-13-20210210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hep.24725","article-title":"Upper limits of normal for alanine aminotransferase activity in the United States population.","volume":"55","author":"Ruhl","year":"2012","journal-title":"Hepatology"},{"key":"R27-13-20210210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s004200050299","article-title":"Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality.","volume":"71","author":"Arndt","year":"1998","journal-title":"Int Arch Occup Environ Health"},{"key":"R28-13-20210210","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.38050.593634.63","article-title":"Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study.","volume":"328","author":"Kim","year":"2004","journal-title":"Br Med J"},{"key":"R29-13-20210210","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.22090","article-title":"Serum aminotransferase activity and mortality risk in a United States community.","volume":"47","author":"Lee","year":"2008","journal-title":"Hepatology"},{"issue":"477-85","key":"R30-13-20210210","first-page":"e11","article-title":"Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.","volume":"136","author":"Ruhl","year":"2009","journal-title":"Gastroenterology"},{"key":"R31-13-20210210","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.21171","article-title":"Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.","volume":"43","author":"Ioannou","year":"2006","journal-title":"Hepatology"},{"key":"R32-13-20210210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1572-0241.2005.00341.x","article-title":"The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.","volume":"101","author":"Ioannou","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R33-13-20210210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-137-1-200207020-00012","article-title":"Alanine aminotransferase levels: Whats normal?","volume":"137","author":"Kaplan","year":"2002","journal-title":"Ann Intern Med"},{"key":"R34-13-20210210","first-page":"693","article-title":"Liver function testing in a working population: three strategies to reduce false-positive results.","volume":"30","author":"Wright","year":"1988","journal-title":"J Occup Environ Med"},{"key":"R35-13-20210210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-9343(00)00381-8","article-title":"Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels.","volume":"109","author":"Nutt","year":"2000","journal-title":"Am J Med"},{"key":"R36-13-20210210","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1053\/j.gastro.2004.09.050","article-title":"Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.","volume":"127","author":"Zeuzem","year":"2004","journal-title":"Gastroenterology"},{"key":"R37-13-20210210","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/gast.1996.v110.pm8613000","article-title":"Long-term survival in patients with hereditary hemochromatosis.","volume":"110","author":"Niederau","year":"1996","journal-title":"Gastroenterology"},{"key":"R38-13-20210210","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"R39-13-20210210","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States.","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R40-13-20210210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1423-0410.1988.tb05083.x","article-title":"Persistent alanine aminotransferase elevation in healthy Swedish blood donorsmainly caused by obesity.","volume":"55","author":"Wejstal","year":"1988","journal-title":"Vox Sang"},{"key":"R41-13-20210210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-156-4-201202210-00378","article-title":"The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.","volume":"156","author":"Rein","year":"2012","journal-title":"Ann Intern Med"},{"key":"R42-13-20210210","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep"},{"key":"R45-13-20210210","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"R46-13-20210210","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"R47-13-20210210","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease.","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"key":"R48-13-20210210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cgh.2014.04.039","article-title":"FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice.","volume":"13","author":"Tapper","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R49-13-20210210","first-page":"145","article-title":"A combination of raised serum AST:ALT ratio and erythrocyte mean cell volume level detects excessive alcohol consumption.","volume":"103","author":"Kawachi","year":"1990","journal-title":"N Z Med J"},{"key":"R50-13-20210210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/alcalc\/agh074","article-title":"High ASTALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking.","volume":"39","author":"Nyblom","year":"2004","journal-title":"Alcohol Alcohol"},{"key":"R52-13-20210210","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.cgh.2015.08.012","article-title":"Autoimmune hepatitis and overlap syndromes: diagnosis and management.","volume":"13","author":"Vierling","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R53-13-20210210","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"key":"R54-13-20210210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","article-title":"Penetrance of 845G A (C282Y) HFE hereditary haemochromatosis mutation in the USA.","volume":"359","author":"Beutler","year":"2002","journal-title":"Lancet"},{"key":"R55-13-20210210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hep.22972","article-title":"HFE C282YH63D compound heterozygotes are at low risk of hemochromatosis-related morbidity.","volume":"50","author":"Gurrin","year":"2009","journal-title":"Hepatology"},{"key":"R56-13-20210210","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/jhep.2003.50252","article-title":"A practice guideline on Wilson disease.","volume":"37","author":"Roberts","year":"2003","journal-title":"Hepatology"},{"key":"R57-13-20210210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMra010772","article-title":"Alpha1-antitrypsin deficiencya model for conformational diseases.","volume":"346","author":"Carrell","year":"2002","journal-title":"N Engl J Med"},{"key":"R59-13-20210210","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.mpg.0000226387.56612.1e","article-title":"Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.","volume":"43","author":"Regev","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R60-13-20210210","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ajg.2010.102","article-title":"The myth of statin-induced hepatotoxicity.","volume":"105","author":"Bader","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R61-13-20210210","first-page":"97","article-title":"Acute cholestatic hepatitis caused by simvastatine in a 67-year-old patient.","volume":"63","author":"Lata","year":"2006","journal-title":"Przegl Lek"},{"key":"R62-13-20210210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12109","article-title":"Review article: herbal and dietary supplement hepatotoxicity.","volume":"37","author":"Bunchorntavakul","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R64-13-20210210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R66-13-20210210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000347210","article-title":"Cholestatic liver disease.","volume":"31","author":"Jungst","year":"2013","journal-title":"Dig Dis"},{"key":"R67-13-20210210","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ajg.2015.192","article-title":"Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population.","volume":"110","author":"Castillo","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R69-13-20210210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.2007.03001.x","article-title":"Muscular exercise can cause highly pathological liver function tests in healthy men.","volume":"65","author":"Pettersson","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R70-13-20210210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archfami.2.4.409","article-title":"Liver function test abnormalities in early Lyme disease.","volume":"2","author":"Kazakoff","year":"1993","journal-title":"Arch Fam Med"},{"key":"R71-13-20210210","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/archinte.158.19.2149","article-title":"Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors.","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"key":"R72-13-20210210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000016901","article-title":"Gastrointestinal and hepatic manifestations of human ehrlichiosis: 8 cases and a review of the literature.","volume":"17","author":"Nutt","year":"1999","journal-title":"Dig Dis"},{"key":"R73-13-20210210","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1056\/NEJMra020282","article-title":"The Budd-Chiari syndrome.","volume":"350","author":"Menon","year":"2004","journal-title":"N Engl J Med"},{"key":"R74-13-20210210","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection.","volume":"44","author":"Alter","year":"2006","journal-title":"J Hepatol"},{"key":"R75-13-20210210","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.2012.186","article-title":"Does this patient with liver disease have cirrhosis?","volume":"307","author":"Udell","year":"2012","journal-title":"JAMA"},{"key":"R76-13-20210210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF02233628","article-title":"Clinical evaluation of liver size and hepatic scintiscan.","volume":"11","author":"Peternel","year":"1966","journal-title":"Am J Dig Dis"},{"key":"R77-13-20210210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2214\/ajr.122.2.313","article-title":"The significance of a palpable liver. A correlation of clinical and radioisotope studies.","volume":"122","author":"Rosenfield","year":"1974","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"R78-13-20210210","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.1994.03510470063036","article-title":"The rational clinical examination. Physical examination of the liver.","volume":"271","author":"Naylor","year":"1994","journal-title":"JAMA"},{"key":"R79-13-20210210","first-page":"1926","article-title":"Parotid hypertrophy and Dupuytrens contracture in liver cirrhosis.","volume":"102","author":"Wegmann","year":"1960","journal-title":"Munch Med Wochenschr"},{"key":"R80-13-20210210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians.","volume":"172","author":"Giannini","year":"2005","journal-title":"Canad Med Assoc J"},{"key":"R81-13-20210210","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.25551","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011.","volume":"55","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"R82-13-20210210","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/BF01324898","article-title":"The SGOTSGPT ratioan indicator of alcoholic liver disease.","volume":"24","author":"Cohen","year":"1979","journal-title":"Dig Dis Sci"},{"key":"R83-13-20210210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF01391646","article-title":"SGOT-SGPT ratios.","volume":"26","author":"Correia","year":"1981","journal-title":"Dig Dis Sci"},{"key":"R84-13-20210210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","article-title":"ASTALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.","volume":"93","author":"Sheth","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R85-13-20210210","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy.","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"R86-13-20210210","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJM197201272860407","article-title":"Alkaline phosphatase.","volume":"286","author":"Kaplan","year":"1972","journal-title":"N Engl J Med"},{"key":"R87-13-20210210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00004836-199008000-00012","article-title":"Isolated elevation of alkaline phosphatase: significance in hospitalized patients.","volume":"12","author":"Lieberman","year":"1990","journal-title":"J Clin Gastroenterol"},{"key":"R88-13-20210210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF01347885","article-title":"Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease.","volume":"30","author":"Moussavian","year":"1985","journal-title":"Dig Dis Sci"},{"key":"R89-13-20210210","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/eurheartj\/ehl086","article-title":"Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women.","volume":"27","author":"Lee","year":"2006","journal-title":"Eur Heart J"},{"key":"R90-13-20210210","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00408-014-9616-3","article-title":"Relationship of serum gamma-glutamyltransferase levels with pulmonary function and chronic obstructive pulmonary disease.","volume":"192","author":"Kim","year":"2014","journal-title":"Lung"},{"key":"R91-13-20210210","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hep.21667","article-title":"A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes.","volume":"46","author":"Fraser","year":"2007","journal-title":"Hepatology"},{"key":"R92-13-20210210","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/BF01300258","article-title":"Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy.","volume":"31","author":"Keeffe","year":"1986","journal-title":"Dig Dis Sci"},{"key":"R93-13-20210210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/clinchem\/18.4.358","article-title":"Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone.","volume":"18","author":"Lum","year":"1972","journal-title":"Clin Chem"},{"key":"R94-13-20210210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0950-3528(89)90004-3","article-title":"Gilberts syndrome.","volume":"3","author":"Watson","year":"1989","journal-title":"Baillieres Clin Gastroenterol"},{"key":"R95-13-20210210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0002-9343(64)90102-0","article-title":"Unconjugated hyperbilirubinemia in the absence of overt hemolysis: Importance of acquired disease as an etiologic factor in 366 adolescent and adult subjects.","volume":"36","author":"Levine","year":"1964","journal-title":"Am J Med"},{"key":"R96-13-20210210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.21480","article-title":"Sepsis-induced cholestasis.","volume":"45","author":"Chand","year":"2007","journal-title":"Hepatology"},{"key":"R97-13-20210210","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJM196703162761101","article-title":"Greenberger and K.J. Isselbacher, Severe postoperative hyperbilirubinemia simulating obstructive jaundice.","volume":"276","author":"Kantrowitz","year":"1967","journal-title":"N Engl J Med"},{"key":"R98-13-20210210","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM196503182721101","article-title":"Benign postoperative intrahepatic cholestasis.","volume":"272","author":"Schmid","year":"1965","journal-title":"N Engl J Med"},{"key":"R99-13-20210210","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2014.03.047","article-title":"Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences.","volume":"146","author":"Erlinger","year":"2014","journal-title":"Gastroenterology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2016517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016517","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201701000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:14:55Z","timestamp":1786547695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201701000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2016.517","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}